Rivaroxaban for Patients With Antiphospholipid Syndrome
Clinical trial NCT02926170 · COMPLETED
Trial details
- NCT number
- NCT02926170
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-13
- Primary completion
- 2017-12-31
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.